Cargando…

Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial

We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15–30). Mont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayo, Ashley J., Browne, Erica N., Montgomery, Elizabeth T., Torjesen, Kristine, Palanee-Phillips, Thesla, Jeenarain, Nitesha, Seyama, Linly, Woeber, Kubashni, Harkoo, Ishana, Reddy, Krishnaveni, Tembo, Tchangani, Mutero, Prisca, Tauya, Thelma, Chitukuta, Miria, Gati Mirembe, Brenda, Soto-Torres, Lydia, Brown, Elizabeth R., Baeten, Jared M., van der Straten, Ariane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222015/ https://www.ncbi.nlm.nih.gov/pubmed/33713213 http://dx.doi.org/10.1007/s10461-021-03205-z

Ejemplares similares

Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study
por: Garcia, Morgan, et al.
Publicado: (2021)

Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention
por: Palanee-Phillips, Thesla, et al.
Publicado: (2015)

Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial
por: Palanee-Phillips, Thesla, et al.
Publicado: (2018)

Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial
por: Brown, Elizabeth R, et al.
Publicado: (2020)

‘‘Ask the way from those who have walked it before”—Grandmothers’ roles in health-related decision making and HIV pre-exposure prophylaxis use among pregnant and breastfeeding women in sub-Saharan Africa
por: Reddy, Krishnaveni, et al.
Publicado: (2022)

After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub‐Saharan Africa
por: Flax, Valerie L., et al.
Publicado: (2020)

Adolescent Girls and Young Women’s Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis
por: Young, Alinda M., et al.
Publicado: (2023)

HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial
por: Parikh, Urvi M., et al.
Publicado: (2021)

Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention
por: Reidy, Meghan, et al.
Publicado: (2019)

Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study)
por: Ngure, Kenneth, et al.
Publicado: (2023)

Increased Dapivirine Tissue Accumulation through Vaginal Film Codelivery of Dapivirine and Tenofovir
por: Akil, Ayman, et al.
Publicado: (2014)

Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2022)

Understanding women’s motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence
por: Katz, Ariana W. K., et al.
Publicado: (2019)

Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study
por: Luecke, Ellen H, et al.
Publicado: (2016)

Sexual Attitudes, Beliefs, Practices, and HIV Risk During Pregnancy and Post-delivery: A Qualitative Study in Malawi, South Africa, Uganda, and Zimbabwe
por: Ryan, Julia H., et al.
Publicado: (2021)

Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
por: Bhavaraju, Neeraja, et al.
Publicado: (2021)

Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
por: Nel, Annalene, et al.
Publicado: (2016)

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial
por: Riddler, Sharon A., et al.
Publicado: (2017)

Editorial: Integration of HIV prevention with sexual and reproductive health services
por: Palanee-Phillips, Thesla
Publicado: (2023)

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States
por: Liu, Albert Y, et al.
Publicado: (2021)

Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa
por: Leslie, Jonah, et al.
Publicado: (2021)

Multiple dosage forms of the NNRTI microbicide dapivirine: product development and evaluation
por: Romano, Joseph
Publicado: (2006)

Antitumor Activity and Mechanism of a Reverse Transcriptase Inhibitor, Dapivirine, in Glioblastoma
por: Liu, Weiwen, et al.
Publicado: (2018)

Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions
por: Zheng, Ruohui, et al.
Publicado: (2022)

The impact of COVID-19 on sexual behavior, HIV prevention interest, general healthcare access, and other HIV risk factors among trial participants in Malawi, South Africa, Uganda, and Zimbabwe
por: Mancuso, Noah, et al.
Publicado: (2023)

Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in Women
por: Jansen van Vuuren, Claudia J., et al.
Publicado: (2023)

Development of a relationship counselling website to identify and mitigate risk of intimate partner violence in the context of women’s PrEP use
por: Hartmann, Miriam, et al.
Publicado: (2023)

Measuring Effects of Counseling to Increase Pre-Exposure Prophylaxis Adherence and Partner Support in South Africa Using the Healthy Relationship Assessment Tool
por: Zissette, Seth, et al.
Publicado: (2023)

Physiologically‐based pharmacokinetic model of vaginally administered dapivirine ring and film formulations
por: Kay, Katherine, et al.
Publicado: (2018)

Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda
por: Kusemererwa, Sylvia, et al.
Publicado: (2022)

Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole
por: Valicherla, Guru Raghavendra, et al.
Publicado: (2021)

Changes in relationships, HIV risk, and feelings towards PrEP: findings from a qualitative explanatory study among participants in the CHARISMA intervention trial
por: Hartmann, Miriam, et al.
Publicado: (2023)

Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High‐risk African Women
por: Kiweewa, Flavia Matovu, et al.
Publicado: (2019)

An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
por: Balkus, Jennifer E., et al.
Publicado: (2016)

Inhibition of HIV Virus by Neutralizing Vhh Attached to Dual Functional Liposomes Encapsulating Dapivirine
por: Wang, Scarlet Xiaoyan, et al.
Publicado: (2016)

Dapivirine Bioadhesive Vaginal Tablets Based on Natural Polymers for the Prevention of Sexual Transmission of HIV
por: Cazorla-Luna, Raúl, et al.
Publicado: (2019)

Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel
por: Li, Jing, et al.
Publicado: (2019)

Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls
por: Farr Zuend, Christina, et al.
Publicado: (2021)

Project BESPOKE (Integrated Bio-Behavioral Assessment of HIV and STI Among Young Tertiary Student Men Who Have Sex With Men in Nairobi, Kenya): A Respondent-Driven Sampling Survey Protocol
por: Mwaniki, Samuel Waweru, et al.
Publicado: (2021)

Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost‐effectiveness
por: Glaubius, Robert, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c415p95ol9r68mqq1eunf9gmgg